EXPLORE RECENT PLACEMENTS

Occam’s European TechBio Practice Accelerates with the Recruitment of Nucleome CEO Mark Bodmer, PhD

Occam Recruits CEO for Khosla, GV, and Third Rock Investment EveryONE Medicines

Occam Places Radu Dobrin as CTO of Deep Genomics

Occam Recruits Human Capital Partner for Prominent Healthcare PE/VC Investor

Occam Places Jim Burns as CEO of Ensoma

Occam Places Chief Development Officer of Groundbreaking Longevity Player, Loyal

Occam Recruits Brent Warner as CEO for Protego Biopharma

Occam Enhances CytomX's Board with Experienced Physician Executive

Occam Places CSO of ADC Biotech MBrace Therapeutics

Occam Places Adrian Schreyer as CTO of Anagenex

Occam Recruits Translational Leader for Gene Editing Leader Mammoth

Occam Recruits CSO for Public Gene Therapy Company, Adverum

Occam Places Biotech Leader David Southwell as Chairman of Revolo Biotherapeutics

Occam Recruits CBO for Parisian Generative AI Drug Discovery Platform Company, Iktos

Occam Recruits Sanjeev Luther as President and CEO of Eterna Therapeutics

Occam's AI Practice Expands with the Recruitment of Dr. Rajiv Patni as Strategic Clinical Advisor to BioXcel Therapeutics

Occam’s UK Biotech Practice Accelerates with Placement of CSO at Nucleome

Occam Recruits CEO of Prominent Rare Disease Research Foundation

Occam Continues to Serve the Gene Therapy/Gene Editing Space, Recruiting Wes Miller as CMO of Epic Bio

Occam Places Senior DeepMind Leader as VP of AI/ML at GSK

Occam Places Manju Ramarao as CSO of Atomic AI

Occam Places Nick Pullen as CSO of ARTBIO

Key Financial Executive Placement Expands Global Tech Practice

Occam Places General Counsel for Public Biopharma KalVista Pharmaceuticals

Occam Recruits Michelle Robertson as CFO of Geron Corporation

Occam Places Chief Legal Officer at Public Oncology Biotech

Occam Places Bryan Stuart as CEO of Atavistik

Occam Places Kimberly Scearce-Levie as Chief Development Officer of Cajal Neuroscience

Occam's Tech Practice Places CRO at Engageli, a Collaborative SW Developer

Occam Places Mark Strobeck on the Board of Windtree

Occam Places CEO for RadioPharm Start-Up

Occam’s UK Practice Expands, Placing Swati Chatterjee as SVP Sales & Business Development of Chemify

Occam Recruits David Moller as Chief Scientific Officer of Variant Bio

Occam Places Brian Piekos as CFO of Elicio Therapeutics

Occam Places R&D Leader David Mauro as CMO at Recursion

Occam’s Global Tech Practice Continues to Expand, Placing Daniel Delubac as COO & CTO at Chemify

Occam Places Andrew Allen as Board Chair of Peptone

Occam Places Ann Taylor as Board Member at Comanche Biopharma

Occam Places Dan Kemp as CEO of Shinobi Therapeutics

Occam Places Kevin Coveney as CFO of Enveric Biosciences